\beta-Intact-VAE: Identifying and Estimating Causal Effects under Limited Overlap

• URL: http://arxiv.org/abs/2110.05225v1
• Date: Mon, 11 Oct 2021 12:43:29 GMT
• Title: \beta-Intact-VAE: Identifying and Estimating Causal Effects under Limited Overlap
• Authors: Pengzhou Wu and Kenji Fukumizu
• Abstract summary: We use a latent variable to model a prognostic score which is widely used in biostatistics and sufficient for treatment effects. We prove that the latent variable recovers a prognostic score, and the model identifies individualized treatment effects. We derive the TE error bounds that enable representations balanced for treatment groups conditioned on individualized features.
• Score: 21.33872753593482
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: As an important problem in causal inference, we discuss the identification and estimation of treatment effects (TEs) under limited overlap; that is, when subjects with certain features belong to a single treatment group. We use a latent variable to model a prognostic score which is widely used in biostatistics and sufficient for TEs; i.e., we build a generative prognostic model. We prove that the latent variable recovers a prognostic score, and the model identifies individualized treatment effects. The model is then learned as \beta-Intact-VAE--a new type of variational autoencoder (VAE). We derive the TE error bounds that enable representations balanced for treatment groups conditioned on individualized features. The proposed method is compared with recent methods using (semi-)synthetic datasets.

Related papers

• Seeing Unseen: Discover Novel Biomedical Concepts via Geometry-Constrained Probabilistic Modeling [53.7117640028211]
  We present a geometry-constrained probabilistic modeling treatment to resolve the identified issues. We incorporate a suite of critical geometric properties to impose proper constraints on the layout of constructed embedding space. A spectral graph-theoretic method is devised to estimate the number of potential novel classes.
  arXiv  Detail & Related papers  (2024-03-02T00:56:05Z)
• Counterfactual Data Augmentation with Contrastive Learning [27.28511396131235]
  We introduce a model-agnostic data augmentation method that imputes the counterfactual outcomes for a selected subset of individuals. We use contrastive learning to learn a representation space and a similarity measure such that in the learned representation space close individuals identified by the learned similarity measure have similar potential outcomes. This property ensures reliable imputation of counterfactual outcomes for the individuals with close neighbors from the alternative treatment group.
  arXiv  Detail & Related papers  (2023-11-07T00:36:51Z)
• Partial Identification of Treatment Effects with Implicit Generative Models [20.711877803169134]
  We propose a new method for partial identification of average treatment effects(ATEs) in general causal graphs using implicit generative models. We prove that our algorithm converges to tight bounds on ATE in linear structural causal models.
  arXiv  Detail & Related papers  (2022-10-14T22:18:00Z)
• Heterogeneous Treatment Effect Estimation for Observational Data using Model-based Forests [0.0]
  We propose modifications to model-based forests to address the confounding issue in observational data. We found that this strategy reduces confounding effects in a simulated study with various outcome distributions. We demonstrate the practical aspects of HTE estimation for survival and ordinal outcomes by an assessment of the potentially heterogeneous effect of Riluzole on the progress of Amyotrophic Lateral Sclerosis.
  arXiv  Detail & Related papers  (2022-10-06T11:49:39Z)
• Benchmarking Heterogeneous Treatment Effect Models through the Lens of Interpretability [82.29775890542967]
  Estimating personalized effects of treatments is a complex, yet pervasive problem. Recent developments in the machine learning literature on heterogeneous treatment effect estimation gave rise to many sophisticated, but opaque, tools. We use post-hoc feature importance methods to identify features that influence the model's predictions.
  arXiv  Detail & Related papers  (2022-06-16T17:59:05Z)
• Robust and Agnostic Learning of Conditional Distributional Treatment Effects [62.44901952244514]
  The conditional average treatment effect (CATE) is the best point prediction of individual causal effects. In aggregate analyses, this is usually addressed by measuring distributional treatment effect (DTE) We provide a new robust and model-agnostic methodology for learning the conditional DTE (CDTE) for a wide class of problems.
  arXiv  Detail & Related papers  (2022-05-23T17:40:31Z)
• Towards Principled Causal Effect Estimation by Deep Identifiable Models [21.33872753593482]
  We discuss the estimation of treatment effects (TEs) under unobserved confounding. We propose Intact-VAE, a new variant of variational autoencoder (VAE), motivated by the prognostic score that is sufficient for identifying TEs.
  arXiv  Detail & Related papers  (2021-09-30T12:19:45Z)
• A Twin Neural Model for Uplift [59.38563723706796]
  Uplift is a particular case of conditional treatment effect modeling. We propose a new loss function defined by leveraging a connection with the Bayesian interpretation of the relative risk. We show our proposed method is competitive with the state-of-the-art in simulation setting and on real data from large scale randomized experiments.
  arXiv  Detail & Related papers  (2021-05-11T16:02:39Z)
• Selecting Treatment Effects Models for Domain Adaptation Using Causal Knowledge [82.5462771088607]
  We propose a novel model selection metric specifically designed for ITE methods under the unsupervised domain adaptation setting. In particular, we propose selecting models whose predictions of interventions' effects satisfy known causal structures in the target domain.
  arXiv  Detail & Related papers  (2021-02-11T21:03:14Z)
• Intact-VAE: Estimating Treatment Effects under Unobserved Confounding [21.33872753593482]
  We propose Intact-VAE, a new variant of variational autoencoder (VAE) motivated by the prognostic score that is sufficient for identifying treatment effects. We theoretically show that, under certain settings, treatment effects are identified by our model, and further, based on the identifiability of our model, our VAE is a consistent estimator with representation balanced for treatment groups.
  arXiv  Detail & Related papers  (2021-01-17T13:03:44Z)
• Bayesian prognostic covariate adjustment [59.75318183140857]
  Historical data about disease outcomes can be integrated into the analysis of clinical trials in many ways. We build on existing literature that uses prognostic scores from a predictive model to increase the efficiency of treatment effect estimates.
  arXiv  Detail & Related papers  (2020-12-24T05:19:03Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.